EntryPoint Capital’s Insmed INSM Stock Holding History

EntryPoint Capital’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,421	Closed	-$205K	–	758
2025 Q3	$205K	Buy	+1,421	New	+$174K	0.08%	542
2025 Q2	–	Sell	-3,997	Closed	-$305K	–	709
2025 Q1	$305K	Buy	3,997 +745	+23%	+$57K	0.14%	315
2024 Q4	$225K	Sell	3,252 -2,311	-42%	-$166K	0.09%	534
2024 Q3	$406K	Buy	5,563 +4,559	+454%	+$336K	0.23%	120
2024 Q2	$67.3K	Sell	1,004 -202	-17%	-$7.83K	0.1%	464
2024 Q1	$32.7K	Buy	+1,206	New	+$33.8K	0.03%	930

Other funds holding INSM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

EntryPoint Capital's INSM Position: Q4 2025 in Review

EntryPoint Capital sold out of Insmed (INSM) in Q4 2025, closing a stake of 1,421 shares — an estimated $205K sold.

EntryPoint Capital first reported a position in INSM in Q1 2024 and held it in 6 quarters. The position peaked at $406K in Q3 2024. 676 funds tracked by Wall St. Rank hold INSM as of Q4 2025.

EntryPoint Capital reported no remaining Insmed position as of Q4 2025 after selling out during the quarter.
EntryPoint Capital sold 1,421 Insmed shares in Q4 2025, an estimated $205K.
EntryPoint Capital first reported a position in Insmed in Q1 2024 and held it in 6 quarters.
EntryPoint Capital's Insmed position peaked at $406K in Q3 2024.
676 funds tracked by Wall St. Rank held Insmed as of Q4 2025.

Based on EntryPoint Capital's 13F filing for Q4 2025, filed 12 Feb 2026.